Overview

Single Ascending Dose (BMS-813160) Study

Status:
Completed
Trial end date:
2010-11-01
Target enrollment:
Participant gender:
Summary
The primary purpose of this study is to evaluate the safety and tolerability of single oral doses of BMS-813160 in healthy subjects
Phase:
Phase 1
Details
Lead Sponsor:
Bristol-Myers Squibb